Insider buying last 90 days
No open-market insider purchases were filed for HR in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every HR insider filing, plotted on the chart in Gekko.Open HR in Gekko
Healthcare Realty Trust (HR) Stock Analysis & Forecast
Sep 28 close
$17.98−0.07 (−0.4%)
Gekko Brief
AI summaryHealthcare Realty Trust has been down 5.8% over four weeks, with recent commentary pointing to technically oversold territory and analysts revising earnings estimates higher, framed as grounds for a possible trend reversal. Institutional filings also surfaced this week, with State Street Corp reducing its stake by 1.9% while retaining 16.74 million shares valued at approximately $337.7 million, even as other institutional investors added to their positions.
The stock closed at $17.98, down 0.4%, sitting between its 50-day average of $19.55 and 200-day average of $18.78, with trend signals mixed. Over the past month the shares are off 6%, though the six-month return remains positive at 6.7%. The GekkoIndex reads 74, placing HR in the Buying zone, down 6.2 over five days. Price sits 10.4% above Gekko Fair Value of $16.29.
Healthcare Realty's next earnings report is set for 29 October 2026, 30 days out and beyond a typical 20-trading-day holding window. The last report on 30 July showed an EPS beat of $0.41 versus $0.40 expected, with a -3.7% reaction; the company has beaten estimates in 5 of the last 8 quarters, with an average absolute reaction of 3.5%. No insider, Congress or unusual options activity appears in the current windows. Seasonality over the past 5 years shows an average 20-day return of 0.4% from this point, positive in 2 of those years. Analyst consensus among 9 firms includes 3 buy and 6 hold ratings, with a consensus target of $21.42.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Healthcare Realty Trust price vs fair value
Close $17.98200-day averageGekko Fair Value $16.29
Healthcare Realty Trust quick facts
- Market cap
- $6.31B
- P/E ratio
- —
- Forward P/E
- 10.8
- EPS, TTM
- −$0.26
- Revenue, TTM
- $1.15B
- Profit margin
- -7.6%
- Dividend yield
- 5.38%
- Beta
- 0.81
- Volume
- 5.15M avg 4.06M
- 1-year return
- +1.7%
- Typical daily move
- ±1.8%
- Typical 20-day move
- ±4.4%
- 50-day average
- $19.55
- 200-day average
- $18.78
- Next earnings
- Oct 29
- Shares outstanding
- 346.5M
Healthcare Realty Trust swing-trade checklist
Healthcare Realty Trust scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed1 headwind
- Trendmixed
Averages disagree
Close $17.98 sits between the 50-day ($19.55) and 200-day ($18.78) averages, or the averages disagree.
See the chart - GekkoIndexsupportive
74, Buying
Reading 74 is in the Buying zone.
See the GekkoIndex - Fair valueheadwind
10.4% above
Price is 10.4% above Gekko Fair Value (more than 5% above).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 30 days
Next report Oct 29, 2026, 30 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitymixed
+0.4% on average
From this point in the calendar, the next 20 trading days averaged +0.4% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
Healthcare Realty Trust stock chart and price history
Healthcare Realty Trust closed at $17.98 on Sep 28, 2026, +1.7% over the past year, inside a 52-week range of $16.31 to $22.04.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- −6.0%
- 3 months
- −12.9%
- 6 months
- +6.7%
- 1 year
- +1.7%
The full HR chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open HR in Gekko
Follow Healthcare Realty Trust through every session
Put HR on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track HR in GekkoFree for 7 days. No credit card required.
About Healthcare Realty Trust
Healthcare Realty Trust invests in real estate that serves outpatient healthcare providers across the United States, buying, developing, financing and managing these income-producing properties. It is known for building a large network of medical office and outpatient facilities rather than traditional commercial space, giving it a distinct footprint among property owners tied to the healthcare field.
As a real estate investment trust, it generates income primarily by owning and leasing these facilities to healthcare tenants, while also handling property management and leasing services on behalf of others. By late September 2020, its holdings included 211 properties spread across 24 states, together covering roughly 15.5 million square feet and carrying a value near $5.5 billion. It also managed leasing and property operations for an additional 11.9 million square feet nationally, extending its reach beyond properties it directly owns.
Its shares trade under the ticker HR.
- Sector
- Finance
- Website
- healthcarerealty.com
Healthcare Realty Trust GekkoIndex: the smart money zone
Healthcare Realty Trust’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 74, in the Buying zone, down 6.2 points over five sessions.
74Buying
Down 6.2 points over five sessions.
Reading for Sep 28, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying (current zone) | 16 | +0.8% | +1.8% | ||
| Accumulation | 184 | +0.2% | +0.6% | ||
| Neutral | 383 | +0.3% | +1.6% | ||
| Distribution | 42 | 0.0% | −1.3% | ||
| Selling | 0 | Not available | |||
Average HR share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Buying readings averaged +3.2% over 20 days. Past behaviour doesn’t guarantee future results.
Buying zone: Smart money likely accumulating heavily. About the five zones →
See every daily GekkoIndex reading plotted over the HR price, zone by zone.Track HR in Gekko
Is Healthcare Realty Trust stock overvalued? Gekko Fair Value
Healthcare Realty Trust trades 10.4% above Gekko Fair Value of $16.29, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Healthcare Realty Trust shares are worth, recalculated every trading day.
$16.29
Gekko Fair Value, Sep 29, 2026
10.4% Overvalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open HR in Gekko
Healthcare Realty Trust insider and Congress trading
No open-market insider purchases were filed for Healthcare Realty Trust, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in HR were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for HR, plotted on the chart in Gekko.Open HR in Gekko
Buybacks
Healthcare Realty Trust has been buying back its own shares.
- Bought back, quarter ended Jun 30, 2026
- $104.6M
- As a share of market cap
- 1.66%
- Trailing four quarters
- $209.9M
From company filings.
Healthcare Realty Trust earnings: next date and track record
Healthcare Realty Trust reports on Oct 29, 2026 (30 days away), and beat the EPS estimate in 5 of its last 8 reports.
Next earnings report
Oct 29, 2026
30 days away
- EPS estimate
- $0.01
- Revenue estimate
- $275.9M
5 of 8reports beat the EPS estimate
±3.5%average move across the report
3 of 8reports followed by a gain
Share-price move across each report
Last earnings call, Jul 30, 2026 AI summary
- What they said
- Healthcare Realty's Q2 2026 earnings call highlighted strong operational execution against the company's one-year-old strategic plan. Management reported outperformance across key metrics — same-store NOI growth averaging 5.7% over the last four quarters, same-store occupancy near 93%, tenant retention ~90%, cash leasing spreads ~4.1% (4.8% this quarter per Robert), and improved lease IRRs and payback periods. Management emphasized leasing momentum (3.5M sq ft year-to-date, ~10% of portfolio) and redevelopment activity (25+ assets, attractive cash-on-cash returns), a successful $700M exchangeable note issuance (upsized), a $400M delayed draw term loan, and ample liquidity. They described disciplined capital allocation: opportunistic share repurchases, capital recycling via dispositions, redevelopments, and JV acquisitions with KKR (roughly $300M in transactions closed/under contract, attractive yields). Management reiterated they have raised guidance every quarter and raised it again this quarter, and noted progress toward multi-year AFFO/AFFO targets though they stopped short of providing a new specific long-term numeric target on the call. The tone was confident and execution-focused, with multiple analysts asking questions about redevelopments, JV activity, yields, and occupancy trends.
- Guidance
- Management stated they have raised guidance every quarter and raised guidance by $0.02 this quarter. They cited a current midpoint AFFO reference of $1.64 for the year-to-date (Peter referenced $1.64 midpoint) and noted upward revisions to same-store NOI guidance (low end up ~50 bps, high end up ~25 bps per Daniel) but did not provide a full numeric revised range on the call. No explicit multi-year numeric guidance was provided on the call beyond referencing the strategic plan targets (e.g., a prior AFFO target range mentioned in questions of $1.97–$1.99 for 2028).
- Risks flagged
- Risks mentioned or implied include: interest rate and refinancing risk (maturities addressed via exchangeable notes and term loan, but refinancing remains a focus), execution risk on redevelopment projects and JV integrations, dependence on continued favorable supply/demand fundamentals and health system demand, and general market/operating risks outlined in SEC filings (forward-looking statements and disclaimers were read at the outset).
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 30, 2026 | $0.41 est $0.40 | $281.8M est $271.6M | −3.7% |
| Apr 30, 2026 | $0.00 est −$0.03 | $267.6M est $283.7M | +4.3% |
| Feb 12, 2026 | −$0.03 est $0.00 | $286.3M est $285.3M | +3.3% |
| Oct 30, 2025 | $0.41 est $0.40 | $297.8M est $285.9M | −0.2% |
| Jul 31, 2025 | $0.41 est $0.40 | $297.5M est $292.3M | +6.3% |
| May 1, 2025 | −$0.10 est −$0.12 | $299.0M est $297.0M | −2.1% |
| Feb 19, 2025 | −$0.16 est −$0.12 | $290.6M est $298.7M | −2.4% |
| Oct 30, 2024 | −$0.26 est −$0.05 | $315.4M est $307.0M | −5.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Healthcare Realty Trust stock forecast and analyst price targets
Analysts’ average 12-month price target for Healthcare Realty Trust is $21.42, +19.1% from the last close, from 9 firms rating the stock in the last 90 days.
$21.42consensus 12-month target, +19.1% from the last close
Now $17.98Avg $21.42
Low $14High $24
Each firm’s latest rating in the last 90 days: 9 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 15 | Jefferies | $20 | +11.2% |
| Sep 1 | Wells Fargo | $20 | +11.2% |
| Aug 21 | UBS | $21 | +16.8% |
| Aug 16 | Goldman Sachs | $14 | −22.1% |
| Aug 7 | RBC Capital | $22 | +22.4% |
+1.8%average 20-day move after past Buying readings
+0.4%average move over the next 20 trading days in the last 5 years
±1.8%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Healthcare Realty Trust seasonality: the next 20 trading days
Over the next 20 trading days from Sep 29, Healthcare Realty Trust averaged +0.4% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.9% | 1 of 5 |
| Next 10 trading days | −1.3% | 2 of 5 |
| Next 15 trading days | +0.4% | 3 of 5 |
| Next 20 trading days | +0.4% | 2 of 5 |
| Next 30 trading days | +0.3% | 3 of 5 |
For scale, HR’s typical 20-trading-day move in either direction is about 4.4%.
Healthcare Realty Trust market cap and key statistics
Healthcare Realty Trust’s market cap is $6.31B and revenue of $1.15B over the last twelve months.
Valuation
- Market cap
- $6.31B
- Forward P/E
- 10.8
- EPS, TTM
- −$0.26
- Gekko Fair Value
- $16.29
Trading
- Volume
- 5.15M
- Avg volume, 20 days
- 4.06M
- 52-week high
- $22.04
- 52-week low
- $16.31
- Shares outstanding
- 346.5M
Financials
- Revenue, TTM
- $1.15B
- Profit margin
- -7.6%
- Return on equity
- -1.9%
- Quarterly earnings growth, YoY
- −76.8%
Risk and income
- Beta
- 0.81
- Typical daily move
- ±1.8%
- Typical 20-day move
- ±4.4%
- Dividend yield
- 5.38%
Healthcare Realty Trust stock news this week
3 headlines about Healthcare Realty Trust from the past week, newest first, each linking to the publisher.
- Corient Private Wealth LP Purchases 30,584 Shares of Healthcare Realty Trust Incorporated $HRDefense World, Sep 28
- State Street Corp Reduces Stock Position in Healthcare Realty Trust Incorporated $HRMarketBeat, Sep 24
- Down 5.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Healthcare Realty Trust (HR)Zacks Investment Research, Sep 21
Healthcare Realty Trust stock FAQ
What is Healthcare Realty Trust’s market cap?
Healthcare Realty Trust’s market cap is $6.31B at the Sep 28, 2026 close of $17.98, with 346.5M shares outstanding.
What is the Healthcare Realty Trust stock forecast?
The consensus analyst 12-month price target for Healthcare Realty Trust is $21.42, +19.1% from the last close. Of the 9 firms that rated the stock in the last 90 days, 3 rate it a buy, 6 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is Healthcare Realty Trust stock overvalued or undervalued?
On Gekko’s estimate Healthcare Realty Trust is overvalued: the Sep 28, 2026 close of $17.98 is 10.4% above Gekko Fair Value of $16.29. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does Healthcare Realty Trust report earnings next?
Healthcare Realty Trust is expected to report on Oct 29, 2026 (30 days away). Analysts expect earnings of $0.01 per share on revenue of $275.9M. Healthcare Realty Trust beat the earnings estimate in 5 of its last 8 reports, moving 3.5% on average across the report.
What is Healthcare Realty Trust’s 52-week high and low?
Healthcare Realty Trust’s 52-week high is $22.04 and its 52-week low is $16.31; it closed at $17.98 on Sep 28, 2026, +1.7% over the past year. Over the last five years the shares peaked at $33.77 on Oct 28, 2021.
Is Healthcare Realty Trust stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (gekkoindex and earnings risk), 2 as mixed (trend and seasonality) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See Healthcare Realty Trust the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.